Oncology Research Review, Issue 31

In this issue:

Adjuvant gemcitabine + capecitabine in resected pancreatic adenocarcinoma
Bevacizumab + CAPOX in advanced small bowel adenocarcinoma
Eliminate neoadjuvant RT in stage II–III rectal AC?
Mutation location within the K/NRAS gene affects mCRC biology
Cost-effectiveness of capecitabine + bevacizumab maintenance in mCRC
Repeated RIT with 131I-labetuzumab in resectable liver metastases
Cetuximab + CRT in SqCC of the anal canal
. . . and in HIV-associated anal carcinoma
Sublingual fentanyl vs SC morphine for cancer pain
2nd-line fluoropyrimidine-based CTX in biliary tract cancer

Please login below to download this issue (PDF)

Subscribe